Applied Clinical Trials-08-01-2020

Integration of Biomarker Validation in Oncology Trials

August 13, 2020

29

7/8

Recent case study highlights the importance of applying statistical rigor throughout the development and validation processes of biomarkers.

Immunomodulators and Cancer Research

August 13, 2020

29

7/8

Distinguishing CAR-T and CPI approaches and the clinical trial challenges and complexities associated with each.

The RACE for Children Act Takes Effect This Month

August 13, 2020

29

7/8

An amendment to Pediatric Research Equity Act, as part of the 2017 FDA Reauthorization Act, goes into effect soon aiming to change the landscape and promote pediatric cancer drug development.

Designing Cell Therapies to Target Solid Tumors

August 13, 2020

29

7/8

A look at one company’s platform approach in enabling the engineering of T-cells to identify and destroy cancer.

Applied Clinical Trials, August 2020 Issue (PDF)

August 13, 2020

Issue PDF

29

7/8

Click here for a link to open the Applied Clinical Trials August 2020 issue in an interactive PDF format.

The Importance of Biomarker Management

August 13, 2020

29

7/8

Exploring the benefits of capturing and integrating molecular biomarker data within clinical trials to build foundations for data assets.

Clinical Trials Can Duck the European GMO Problem

August 13, 2020

29

7/8

Amid the COVID-19 pandemic, the EU is allowing trials to start before the requirements of directives dating back as far as 2001 have been met.

News Notes

August 13, 2020

29

7/8

A compilation of recent notable news developments that pertain to the clinical trials industry.

Initial Design Considerations for Immuno-Oncology Trials

August 13, 2020

29

7/8

Perspectives and insights regarding regulatory considerations when planning and conducting immunotherapy studies.